Clinical Trial Update: Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE) [NA]

View source ↗

Summary

Clinical trial update indicates ongoing recruitment for Equecabtagene autoleucel (Eque-cel), a CAR-T therapy, for relapsed/refractory systemic lupus erythematos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Equecabtagene autoleucel (equecabtagene autoleucel)

Snippet

Sponsor: Tongji Hospital | Conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN) | NA | Status: RECRUITING